General MedicationsORALGeneric

PREDNISOLONE SODIUM PHOSPHATE

Standard Dose

EQ 30MG BASE/5ML

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PREDNISOLONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 204962 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION;ORAL - EQ 30MG BASE/5ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2024-06-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview PREDNISOLONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 204962 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PREDNISOLONE SODIUM PHOSPHATE Form and strength SOLUTION;ORAL - EQ 30MG BASE/5ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2024-06-05 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.